Protein Sciences Corporation
Biotechnology ResearchConnecticut, United States11-50 Employees
Protein Sciences Corporation is a biotechnology firm based in Meriden, Connecticut, that focuses on vaccine development and recombinant protein production. It pursues the development of innovative vaccines and biopharmaceuticals to address changing health needs. The company employs a proprietary protein expression platform to produce high-quality recombinant proteins quickly, reliably, and at lower cost. Its business is organized into three main lines: proprietary vaccines, GeneXpress product development and manufacturing services, and research antigens. It collaborates with external partners to develop and manufacture modern vaccines, therapeutics, and gene therapies, and it provides purified antigens and antibodies for disease research. In 2022 it announced CIPPS, a Centre of Excellence for Innovations in Peptide and Protein Science, aimed at developing new proteins for food production and medical applications.